| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0098 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |